FOXP3 and neoplasm: In addition to reducing the Foxp3+ T cells in the tumour microenvironment, our data reveal that the Th17-supporting transcription factor RORγt profoundly alters the phenotype of tumour-associated Foxp3+ T cells (Fig. 2b,c).